- Filed
- Feb 21, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 14, 2025 | 111.25M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $188.86M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $750.22M |
| Current Assets | FY 2024 · Dec 31, 2023 | $235.95M |
| Total Assets | FY 2024 · Dec 31, 2023 | $446.92M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 95.92M sh |
| Capex | FY 2024 · Dec 31, 2022 | $22.86M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$91.56M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $293.79M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$2.05 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$2.05 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $195.34M |
| Net Income | FY 2024 · Dec 31, 2022 | −$196.45M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$189.16M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $348.69M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $254.8M |
| Revenue | FY 2024 · Dec 31, 2022 | $603.49M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $73.13M |